Selected Quarterly Financial Information - Summary of Company's Selected Quarterly Financial Information (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2014 |
Sep. 30, 2014 |
Jun. 30, 2014 |
Mar. 31, 2014 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Net revenue | $ 741,740 | $ 722,273 | $ 676,588 | $ 639,395 | $ 650,525 | $ 626,506 | $ 595,544 | $ 566,338 | $ 2,779,996 | $ 2,438,913 | $ 2,154,012 |
Practice salaries and benefits | 461,074 | 450,033 | 422,803 | 419,595 | 404,345 | 394,794 | 372,216 | 372,040 | 1,753,505 | 1,543,395 | 1,361,318 |
Practice supplies and other operating expenses | 26,164 | 24,007 | 24,878 | 23,431 | 23,549 | 21,570 | 22,466 | 21,417 | 98,480 | 89,002 | 82,388 |
General and administrative expenses | 85,393 | 80,185 | 72,401 | 67,936 | 67,641 | 60,643 | 60,829 | 58,414 | 305,915 | 247,527 | 218,209 |
Depreciation and amortization | 18,149 | 16,918 | 15,549 | 13,612 | 13,903 | 11,356 | 10,361 | 10,370 | 64,228 | 45,990 | 39,966 |
Total operating expenses | 590,780 | 571,143 | 535,631 | 524,574 | 509,438 | 488,363 | 465,872 | 462,241 | 2,222,128 | 1,925,914 | 1,701,881 |
Income from operations | 150,960 | 151,130 | 140,957 | 114,821 | 141,087 | 138,143 | 129,672 | 104,097 | 557,868 | 512,999 | 452,131 |
Investment and other income | 751 | 567 | 384 | 142 | 195 | 563 | 335 | 1,635 | 1,844 | 2,728 | 1,696 |
Interest expense | (8,493) | (6,201) | (5,149) | (3,267) | (3,313) | (2,019) | (2,188) | (1,371) | (23,110) | (8,891) | (5,415) |
Equity in earnings of unconsolidated affiliate | 777 | 784 | 745 | 821 | 905 | 725 | 150 | 3,127 | 1,780 | ||
Total non-operating expenses | (6,965) | (4,850) | (4,020) | (2,304) | (2,213) | (731) | (1,703) | 264 | (18,139) | (4,383) | (3,719) |
Income before income taxes | 143,995 | 146,280 | 136,937 | 112,517 | 138,874 | 137,412 | 127,969 | 104,361 | 539,729 | 508,616 | 448,412 |
Income tax provision | 51,581 | 55,640 | 52,889 | 43,928 | 50,594 | 51,174 | 48,944 | 40,701 | 204,038 | 191,413 | 167,895 |
Net income | 92,414 | 90,640 | 84,048 | 68,589 | 88,280 | 86,238 | 79,025 | 63,660 | 335,691 | 317,203 | 280,517 |
Net (income) loss attributable to noncontrolling interests | 288 | 141 | 82 | 118 | 118 | (31) | (9) | 629 | 78 | ||
Net income attributable to MEDNAX, Inc. | $ 92,702 | $ 90,781 | $ 84,130 | $ 68,707 | $ 88,398 | $ 86,207 | $ 79,016 | $ 63,660 | $ 336,320 | $ 317,281 | $ 280,517 |
Earnings per share, Basic | $ 1.00 | $ 0.98 | $ 0.91 | $ 0.73 | $ 0.90 | $ 0.87 | $ 0.80 | $ 0.64 | $ 3.61 | $ 3.22 | $ 2.83 |
Earnings per share, Diluted | $ 0.99 | $ 0.97 | $ 0.90 | $ 0.72 | $ 0.89 | $ 0.86 | $ 0.79 | $ 0.63 | $ 3.58 | $ 3.18 | $ 2.78 |
Weighted average shares, Basic | 92,790 | 92,949 | 92,500 | 94,231 | 98,066 | 99,088 | 98,411 | 99,076 | 93,077 | 98,588 | 99,112 |
Weighted average shares, Diluted | 93,536 | 93,646 | 93,495 | 95,325 | 99,129 | 100,145 | 99,866 | 100,696 | 93,960 | 99,887 | 100,969 |
X | ||||||||||
- Definition Practice salaries and benefits. No definition available.
|
X | ||||||||||
- Definition The aggregate amount of supplies and other operating expenses directly attributable to the physician practices. No definition available.
|
X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|